You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 166 No. 16, September 18, 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (4)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Cardiovascular System
 •Arrhythmias
 •Diabetes Mellitus
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Deranged Glucose Metabolism

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We applaud van der Hooft et al1 in their study, demonstrating that the risk of new-onset atrial fibrillation (AF) was significantly higher for persons who received a corticosteroid prescription within 1 month before the index date than for those without (odds ratio [OR], 3.75; 95% confidence interval [CI], 2.38-5.87). The fact that only high-dose corticosteroid use was associated with an increased risk (OR, 6.07; 95% CI, 3.90-9.42), whereas low to intermediate dose corticosteroid use was not (OR, 1.42; 95% CI, 0.72-2.82), and that the association of AF with high-dose corticosteroid use was largely independent of the indication for corticosteroid therapy suggests that one possible explanation could be the sudden derangement in glucose metabolism resulting in fluctuating levels of glycemic control,2 which occurs with high-dose corticosteroid therapy. Indeed, previous reports have demonstrated that high glucose levels had a positive significant association with the risk of AF.3-4 Nearly a decade ago, Psaty . . . [Full Text of this Article]


AUTHOR INFORMATION
George I. Varughese, MRCP; John H. B. Scarpello, MD, FRCP



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Corticosteroids and the Risk of Atrial Fibrillation
Cornelis S. van der Hooft, Jan Heeringa, Guy G. Brusselle, Albert Hofman, Jacqueline C. M. Witteman, J. Herre Kingma, Miriam C. J. M. Sturkenboom, and Bruno H. Ch. Stricker
Arch Intern Med. 2006;166(9):1016-1020.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Putative Link Between Glycemic Control and Cardiac Arrhythmias
Varughese et al.
Arch Intern Med 2007;167:1433-1434.
FULL TEXT  

Impaired glucose tolerance and the risk of ischaemic stroke: another focus
Varughese et al.
Age Ageing 2007;36:350-351.
FULL TEXT  

Optimizing diabetes care: perspectives from a practical view point
Varughese et al.
JRSM 2007;100:67-67.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.